10-Q: HCMC Reports Q2 2025 Loss, Internal Control Issues

Healthier Choices Management Corp. reported an increased net loss for Q2 2025, alongside negative working capital and identified material weaknesses in its internal controls over financial reporting.

Summary

• Net loss from continuing operations increased to $1.99 million for the three months ended June 30, 2025, and $4.18 million for the six months ended June 30, 2025, compared to $1.91 million and $4.07 million for the respective prior year periods.
• Sales remained de minimis at $1,000 for the three months ended June 30, 2025, and $2,780 for the six months ended June 30, 2025, as the company shifted focus to wholesale and online channels after closing brick-and-mortar vape stores.
• The company reported negative working capital of $2.6 million as of June 30, 2025, with cash and cash equivalents at $1.12 million.
• Management identified material weaknesses in internal controls over financial reporting, including issues with disclosure controls, segregation of duties, and IT controls.
• The Philip Morris patent infringement lawsuit was voluntarily dismissed on December 31, 2024, following a USPTO ruling that the patent was not patentable.
• A patent infringement lawsuit against R.J. Reynolds Vapor Company (RJR) regarding Vuse electronic cigarettes is ongoing, with a USPTO decision on institution expected after January 2025.
• The company's liquidity needs have been satisfied through financing agreements with private lenders, and it believes current cash and a $5 million line of credit will cover obligations for at least the next 12 months.
• The "Due to related party" balance significantly increased to $2.11 million as of June 30, 2025, reflecting continued funding from HCWC to support HCMC's operations during the transition period.

Sentiment

Score: 2

Explanation: The company continues to report significant net losses and negative working capital, with sales remaining de minimis. The voluntary dismissal of the Philip Morris patent lawsuit due to the patent being ruled unpatentable is a major setback for its intellectual property monetization strategy. Furthermore, the disclosure of material weaknesses in internal controls over financial reporting raises serious concerns about governance and financial reliability. While management has plans to raise capital and reduce costs, the historical performance and current financial state indicate substantial challenges.

Positives

• Net cash used in operating activities decreased to $1.99 million for the six months ended June 30, 2025, from $2.47 million in the prior year period.
• The company successfully paid off its $453,232 line of credit balance in full on January 3, 2025.
• The company believes its cash on hand and ability to draw on a $5 million line of credit will enable it to meet obligations for at least the next twelve months.
• One lawsuit related to electronic cigarette battery defects was dismissed with no economic impact to the company, and the $1.5 million settlement for a second case was fully paid by June 30, 2025.

Negatives

• Net loss from continuing operations increased for both the three and six months ended June 30, 2025, compared to the prior year periods.
• Sales remained de minimis, indicating a lack of significant revenue generation from continuing operations.
• The company has negative working capital of $2.6 million as of June 30, 2025.
• Gross profit was negative for both the three and six months ended June 30, 2025, indicating that cost of sales exceeded net sales.
• The Philip Morris patent infringement lawsuit, a significant intellectual property asset, was voluntarily dismissed after the patent was ruled not patentable.
• The company continues to report net losses and cash outflows from operations.
• The "Due to related party" balance increased significantly, indicating reliance on funding from the spun-off entity.

Risks

• The company currently and historically reports net losses and cash outflows from operations, raising going concern uncertainties.
• The ability to reduce outside consulting expenses and secure additional capital from outside investors is uncertain.
• There is no assurance that pending patent applications will be awarded or that existing patents can be monetized.
• Dependence on third-party manufacturers for products introduces potential for supply interruption or inconsistency.
• Cash and cash equivalents are concentrated in one financial institution, exceeding FDIC coverage limits.
• Material weaknesses in internal control over financial reporting, including ineffective disclosure controls, lack of segregation of duties, and inadequate IT controls, pose risks to financial reporting reliability.
• The ongoing patent infringement lawsuit against R.J. Reynolds Vapor Company (RJR) carries inherent litigation risks.

Future Outlook

Management anticipates that current cash on hand and the ability to draw on its $5 million line of credit will be sufficient to meet projected operating expenses and capital requirements for at least the next twelve months. The company plans to reduce certain costs, particularly outside consulting expenses, and secure additional capital from outside investors, though there is no assurance these plans will be successful. The company expects to continue incurring losses for the foreseeable future.

Management Comments

• "The Company believes its cash on hand and its ability to draw on its $5 million line of credit will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date these financial statements are issued."
• "Management has made plans to reduce certain costs and raise the capital needed, however there can be no assurance the Company can successfully implement these plans."
• "The success of these plans is dependent upon various factors, foremost being the ability to reduce outside consulting expenses and the ability to secure additional capital from outside investors."
• "The Company closed all its brick-and-mortar retail vape stores, as management had shifted its retail sales focus to the wholesale and online channel."
• "We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of June 30, 2025."

Industry Context

HCMC operates in the intellectual property monetization and vaping product sectors. The shift from brick-and-mortar retail to wholesale and online channels aligns with broader trends in consumer goods, particularly for niche products like vaping. The ongoing patent litigation highlights the competitive and litigious nature of the intellectual property landscape, especially in rapidly evolving industries like vaping and alternative tobacco products. The company's reliance on third-party manufacturing is common for smaller players in hardware-intensive industries, but also introduces supply chain risks.

Comparison to Industry Standards

• The de minimis sales and negative gross profit are significantly below industry standards for a healthy operating company, indicating a lack of sustainable revenue generation from continuing operations.
• The company's negative working capital of $2.6 million suggests a strained liquidity position, which is generally a red flag compared to financially stable companies that maintain positive working capital.
• The ongoing reliance on related party funding (from HCWC) and the need to secure additional capital from outside investors indicate a financial position weaker than many industry peers that can self-fund or access traditional credit markets more readily.
• The dismissal of the Philip Morris patent infringement case due to the patent being ruled unpatentable is a significant setback, contrasting with successful patent enforcement by larger, well-resourced intellectual property holders in the technology and consumer goods sectors.
• The identified material weaknesses in internal controls are a serious concern, indicating a lack of robust financial governance compared to established public companies, which typically have strong internal control frameworks.

Corporate Governance

Legal Proceedings

• One lawsuit related to alleged electronic cigarette battery defects was dismissed, with the plaintiff settling with the company's insurance carrier, resulting in no economic impact to the company.
• A second lawsuit concerning alleged electronic cigarette battery defects was settled for $1.5 million, which was fully paid by June 30, 2025.
• The patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. (regarding IQOS) was voluntarily dismissed by HCMC on December 31, 2024, after the U.S. Court of Appeals for the Federal Circuit denied HCMC's appeal of a USPTO ruling that the patent was not patentable.
• An ongoing patent infringement lawsuit was filed against R.J. Reynolds Vapor Company (RJR) on September 26, 2023, alleging infringement by RJR's Vuse electronic cigarette. RJR filed a motion to dismiss on November 17, 2023, and an inter partes review at the USPTO on September 18, 2024. A decision on institution from the USPTO is expected after January 2025.

Related Party Transactions

• HCMC provided human resources, accounting, payroll processing, legal, and other managerial services to HCWC prior to the Spin-Off.
• Following the Spin-Off, HCMC and HCWC entered into a Transition Services Agreement (TSA) for transitional services (IT, accounting, HR, payroll) for up to one year.
• Management uses a 50% proportional cost allocation method for shared expenses between HCMC and HCWC.
• HCWC directly funds its 50% share of shared costs and records it as Operating Expenses.
• The "Due to Related Party" balance increased to $2.11 million as of June 30, 2025, from $0.19 million at December 31, 2024, reflecting continued short-term cash advances from HCWC to HCMC to support HCMC's operations during the transition period, repayable within 12 months.

Stakeholder Impact

• Shareholders: Face significant dilution risk from potential future capital raises and conversions of preferred stock. The ongoing net losses, negative working capital, and the dismissal of a key patent lawsuit (Philip Morris) negatively impact shareholder value. The identified internal control weaknesses also pose a risk to investor confidence.
• Employees: The company's financial instability and ongoing losses could impact job security, although management plans to increase headcount in certain areas.
• Customers: The shift to wholesale and online channels and closure of brick-and-mortar stores may alter customer access to products. De minimis sales suggest limited customer engagement.
• Suppliers: Dependence on third-party manufacturers means suppliers are critical, but the company's financial health could pose risks to supplier relationships if payments are delayed or uncertain.
• Creditors: The negative working capital and reliance on related party funding indicate increased credit risk. The $5 million line of credit is a key liquidity source.

Next Steps

• Reduce outside consulting expenses.
• Secure additional capital from outside investors.
• Increase headcount with strong internal control backgrounds and inventory expertise.
• Establish policies and procedures in the IT area to mitigate data breach, unauthorized access, and address segregation of duties.
• Review key third-party service provider SOC reports.
• Continue to pursue the patent infringement lawsuit against R.J. Reynolds Vapor Company.
• Decision on institution for RJR inter partes review by USPTO sometime after January 2025.
• Series E Preferred Stock purchasers' obligation to acquire Series A Preferred Stock completion date extended to October 31, 2025.

Key Dates

Recommendation

HCMC's Q2 2025 filing reveals a deeply concerning financial state, marked by increasing net losses, de minimis sales, and persistent negative working capital. The voluntary dismissal of the Philip Morris patent infringement lawsuit, a cornerstone of its intellectual property monetization strategy, due to the patent being ruled unpatentable, is a severe blow to its core business model. Furthermore, the disclosure of material weaknesses in internal controls over financial reporting indicates fundamental governance and operational deficiencies, eroding investor confidence. While management outlines plans to raise capital and reduce costs, the company's historical performance and current trajectory suggest a high probability of continued financial distress and potential further dilution. The ongoing reliance on funding from the spun-off entity (HCWC) underscores its inability to generate sufficient cash from its own operations. Given these significant red flags, the stock presents a high-risk, low-reward profile, making it a strong sell for investors.

Keywords

HCMC, Quarterly Report, SEC Filing, Financial Results, Patent Infringement, Q-Cup Technology, Vaping Industry, Intellectual Property, Going Concern, Internal Controls, SEC 10-Q, Cannabis, CBD, Vape Products